Open Access

ARTICLE

Leveraging diverse cell-death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: Based on muti-omics analysis and vitro assay

HONGYUAN LIANG^1,#, YANQIU LI^2,#, YONGGANG QU³, LINGYUN ZHANG^4,*

1 Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China
2 Department of Nephrology, The First Affiliated Hospital of China Medical University, Shenyang, China
3 Department of Clinical Medicine, China Medical University, Shenyang, China
4 Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

* Corresponding Author: LINGYUN ZHANG. Email:
# These authors contributed equally to this work